Lung cancer is the number one cause of cancer-related death among South Carolinians – more than breast, prostate, and colon cancers combined. The goal of MUSC’s Thoracic Cancer Program is to offer comprehensive, efficient care for lung cancer patients in a multidisciplinary setting.
Our specialists offer state-of-the-art expertise in bronchoscopic techniques, minimally invasive surgery, molecular profiling of tumors and personalized therapy with chemotherapeutic and targeted agents based on an individual patients’ molecular characteristics.
This team approach means that in just one day, and under one roof, lung cancer patients receive the benefit from consultations from several specialists, including:
- medical oncologists
- thoracic surgeons
- radiation oncologists
- palliative care specialists
- molecular biologists
Then, working together in weekly Tumor Boards, our team reviews complex cases and develops the best possible treatment options for patients and their caregivers to review. When a patient is battling lung cancer, time is of the essence and developing an optimal treatment strategy in a timely manner is critical.
Learn more about MUSC’s Thoracic Cancer Program or call (843) 792-1414.
Guest Author: Dr. George R. Simon is a Medical Oncologist and Assistant Director of Clinical Investigation at the Medical University of South Carolina’s Hollings Cancer Center. Dr. Simon is a nationally known lung cancer researcher and serves as Director of the Center of Economic Excellence (CoEE) in Tobacco Related Malignancy Research. He also holds The Burtschy Family Distinguished Endowed Chair in Lung Cancer Research within the Department of Medicine, Division of Hematology-Oncology.